+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal (Pigs, Cattle), By Drug Class (Tetracyclines, Penicillins), By Dosage Form (Oral Powders, Oral Solutions), By Country (UK, Germany), And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • November 2024
  • Region: Europe
  • Grand View Research
  • ID: 5681742
Description Jump to:
The Europe veterinary antibiotics market size is estimated to reach USD 1.43 billion by 2030, registering a CAGR of 2.31% from 2025 to 2030. The rising focus on animal-only antibiotics and ionophores, the launch of new products, and the increasing use of veterinary antibiotics are some of the major factors augmenting the industry's growth. In addition, the rising prevalence and incidence of livestock diseases and concerns regarding zoonoses are further propelling the industry's growth. The COVID-19 pandemic has affected the veterinary antibiotic business operations of key players and resulted in declined financial performance during the initial time.

The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, with the easing of restrictions, manufacturers were able to supply antibiotics to meet the necessary veterinary requirements. Few major players have reported significant growth in antibiotic sales despite the pandemic. For instance, Virbac’s bovine antibiotic sales grew from USD 66.98 million in 2020 to USD 79.30 million in 2021. The global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Despite the regulatory changes implemented by the European Medicines Agency (EMA) for restriction and ban on routine antibiotic use, the overall sales of veterinary antimicrobial active ingredients have observed significant growth in the past few years.

For instance, according to the EMA, overall veterinary antimicrobial active substance sales grew from 5,282 tonnes in 2019 to 5,562 tonnes in 2020. Furthermore, major players, such as Elanco, have shifted their focus to animal-only antibiotics, as a measure to address antibiotic resistance while also protecting animal health. Key players are implementing various strategic initiatives, such as mergers, partnerships, acquisitions, collaborations, and new product launches, to maintain their competitive edge. For instance, in December 2021, Virbac, in collaboration with Pharmgate, launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These activities are expected to intensify the competition between major antibiotic manufacturers in the coming years.

Europe Veterinary Antibiotics Market Report Highlights

  • The cattle animal type segment accounted for the largest revenue share in 2024 owing to the easy availability of cattle antibiotics and increased consumption of beef & dairy products
  • By drug class, the penicillin segment held the largest revenue share in 2024. Penicillinis one of the most commonly sold antibiotic drug classes in Europe for veterinary application
  • The oral solution segment led the market in 2024 owing to the easy & convenient usage of these dosage forms. These solutions are preferably dispensed in the drinking water
  • Key factors contributing to the notable share of the U.K. include the easy availability of veterinary antibiotics and an increase in pet ownership & pet insurance rates
  • The industry is fairly competitive owing to the presence of major players. Various strategic initiatives implemented by companies are greatly contributing to the growth of the industry.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Scope
1.1.2. Estimates And Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.2. Global Market: CAGR Calculation
1.7. Research Scope and Assumptions
1.7.1. List of Secondary Sources
1.7.2. List of Primary Sources
1.7.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Europe Veterinary Antibiotics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising focus on animal-only antibiotics and ionophores
3.2.1.2. Growing Initiatives by key companies or launch of new products
3.2.1.3. Prudent and responsible use of antibiotics
3.2.2. Market Restraints Analysis
3.2.2.1. Stringent regulations
3.2.2.2. Decline in use of antibiotics
3.2.2.3. Active research on antibiotic alternatives
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenges Analysis
3.3. Europe Veterinary Antibiotics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal landscape
3.4. COVID-19 Analysis
3.5. Patent-Off Dates Analysis for Major Veterinary Antibiotics
3.6. Product Pipeline Analysis
3.7. Estimated Pet Population, by key countries
Chapter 4. Europe Veterinary Antibiotics Market: Animal Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Europe Veterinary Antibiotics Market Movement Analysis
4.3. Europe Veterinary Antibiotics Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
4.4. Pigs
4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Cattles
4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Sheep & Goats
4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Poultry
4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Europe Veterinary Antibiotics Market: Drug Class Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Europe Veterinary Antibiotics Market Movement Analysis
5.3. Europe Veterinary Antibiotics Market Size & Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
5.4. Tetracyclines
5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Penicillins
5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Sulfonamides
5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Macrolides
5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.8. Trimethoprim
5.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.9. Lincosamides
5.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.10. Polymyxins
5.10.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.11. Aminoglycosides
5.11.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.12. Fluoroquinolones
5.12.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.13. Pleuromutilins
5.13.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.14. Other Drug Class
5.14.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Europe Veterinary Antibiotics Market: Dosage Form Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Europe Veterinary Antibiotics Market Movement Analysis
6.3. Europe Veterinary Antibiotics Market Size & Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
6.4. Oral Powders
6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Oral Solutions
6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Injections
6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Europe Veterinary Antibiotics Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. Europe
7.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Insights
7.3.2.3. Germany Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Insights
7.3.3.3. UK Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Insights
7.3.4.3. France Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Insights
7.3.5.3. Italy Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Insights
7.3.6.3. Spain Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Netherlands
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Insights
7.3.7.3. Netherlands Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Insights
7.3.8.3. Denmark Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Belgium
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Insights
7.3.9.3. Belgium Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.10. Hungary
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Insights
7.3.10.3. Hungary Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.11. Poland
7.3.11.1. Key Country Dynamics
7.3.11.2. Competitive Insights
7.3.11.3. Poland Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.12. Portugal
7.3.12.1. Key Country Dynamics
7.3.12.2. Competitive Insights
7.3.12.3. Portugal Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.13. Romania
7.3.13.1. Key Country Dynamics
7.3.13.2. Competitive Insights
7.3.13.3. Romania Veterinary Antibiotics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heat Map Analysis
8.3. Estimated Company Market Share Analysis, 2024
8.4. Strategy Mapping
8.4.1. Mergers & Acquisitions
8.4.2. Partnerships & Collaborations
8.4.3. Others
8.5. Company Profiles
8.5.1. Elanco
8.5.1.1. Participant’s Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Boehringer Ingelheim International GmbH.
8.5.2.1. Participant’s Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Zoetis
8.5.3.1. Participant’s Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Merck & Co., Inc.
8.5.4.1. Participant’s Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Ceva
8.5.5.1. Participant’s Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Vetoquinol S.A.
8.5.6.1. Participant’s Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Virbac
8.5.7.1. Participant’s Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Calier
8.5.8.1. Participant’s Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Bimeda, Inc.
8.5.9.1. Participant’s Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Prodivet pharmaceuticals sa/nv.
8.5.10.1. Participant’s Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
Chapter 9. Key Takeaways
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Europe Veterinary Antibiotics Market, By Country, 2018 - 2030 (USD Million)
Table 4. Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 5. Europe Veterinary Antibiotics Market, By Drug class, 2018 - 2030 (USD Million)
Table 6. Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 7. Europe Veterinary Antibiotics Market, By Country, 2018 - 2030 (USD Million)
Table 8. Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 9. Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 10. Europe Veterinary Antibiotics Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 11. UK Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 12. UK Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 13. UK Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 14. Germany Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 15. Germany Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 16. Germany Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 17. France Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 18. France Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 19. France Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 20. Italy Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 21. Italy Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 22. Italy Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 23. Spain Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 24. Spain Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 25. Spain Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 26. Denmark Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 27. Denmark Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 28. Denmark Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 29. Sweden Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 30. Sweden Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 31. Sweden Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 32. Norway Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 33. Norway Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 34. Norway Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 35. Netherlands Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 36. Netherlands Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 37. Netherlands Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 38. Belgium Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 39. Belgium Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 40. Belgium Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 41. Hungary Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 42. Hungary Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 43. Hungary Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 44. Poland Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 45. Poland Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 46. Poland Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 47. Portugal Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 48. Portugal Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 49. Portugal Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
Table 50. Romania Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Million)
Table 51. Romania Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Million)
Table 52. Romania Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Europe Veterinary Antibiotics market segment scope and defination
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 Europe Veterinary Antibiotics market: Animal type movement analysis
Fig. 16 Europe Veterinary Antibiotics market: Animal type segment dashboard
Fig. 17 Europe Veterinary Antibiotics market Animal type outlook: Key takeaways
Fig. 18 Pigs Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Cattle Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Sheep & Goats Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Poultry Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Other Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Europe Veterinary Antibiotics market: Drug Class movement analysis
Fig. 24 Europe Veterinary Antibiotics market Drug Class outlook: Key takeaways
Fig. 25 Tetracyclines Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Penicillins Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Sulfonamides Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Macrolides Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Trimethoprim Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Lincosamides Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Polymyxins Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Aminoglycosides Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Fluoroquinolones Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Pleuromutilins Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Other Drug Class Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Europe Veterinary Antibiotics market: Dosage Form movement analysis
Fig. 37 Europe Veterinary Antibiotics market Dosage Form outlook: Key takeaways
Fig. 38 Oral Powders Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Oral Solutions Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Injections Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Other Dosage Form Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Country outlook, 2024 & 2030
Fig. 43 Country market dashboard
Fig. 44 Country market place: Key takeaways
Fig. 45 Europe Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 46 UK Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 47 Germany Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 48 Spain Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 49 France Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 50 Italy implantable Market, 2018 - 2030 (USD Million)
Fig. 51 Denmark Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 52 Sweden Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 53 Norway Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 54 Netherlands Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 55 Belgium Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 56 Poland Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 57 Portugal Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 58 Hungary implantable Market, 2018 - 2030 (USD Million)
Fig. 59 Romania Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Million)
Fig. 60 Heat map analysis

Companies Mentioned

  • Merck & Co., Inc.
  • Ceva
  • Zoetis
  • Boehringer Ingelheim GmbH
  • Elanco
  • Vetoquinol S.A.
  • Virbac
  • Calier
  • Bimeda, Inc.
  • Prodivet Pharmaceuticals SA/NV

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.43 Billion
Compound Annual Growth Rate2.3%
Regions CoveredEurope
No. of Companies Mentioned10

Related Topics

Related Reports

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030 - Product Image

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030

  • Report
  • 258 Pages
  • Global
From
Veterinary Antibiotics Market by Class (Aminoglycosides, Amphenicols, Cephalosporins), Animal Type (Companion Animals, Livestock), End-user, Therapeutic Areas - Global Forecast 2025-2030 - Product Image

Veterinary Antibiotics Market by Class (Aminoglycosides, Amphenicols, Cephalosporins), Animal Type (Companion Animals, Livestock), End-user, Therapeutic Areas - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Europe Veterinary Antibiotics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F - Product Image

Europe Veterinary Antibiotics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F

  • Report
  • 125 Pages
  • Europe
From
Veterinary Antibiotics Global Market Report 2024 - Product Image

Veterinary Antibiotics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Veterinary Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Veterinary Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From

About the Veterinary Antibiotics Market

The Veterinary Antibiotics market is a segment of the Animal Healthcare/Veterinary industry that focuses on the production and distribution of antibiotics for use in animals. Veterinary antibiotics are used to treat a variety of bacterial infections in animals, including respiratory, gastrointestinal, and urinary tract infections. They are also used to prevent and control the spread of infectious diseases in animals. Veterinary antibiotics are available in a variety of forms, including tablets, capsules, liquids, and injectables. Veterinary antibiotics are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. Veterinary antibiotics are typically prescribed by veterinarians and dispensed by pharmacies. In some cases, they may be available over-the-counter. Some companies in the Veterinary Antibiotics market include Bayer, Merck, Zoetis, Elanco, and Boehringer Ingelheim. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.